Sotera Health Company (NASDAQ:SHC) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Sotera Health Company (NASDAQ:SHC) have received a consensus rating of “Moderate Buy” from the ten analysts that are currently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $20.00.

Several brokerages have recently weighed in on SHC. Piper Sandler upgraded shares of Sotera Health from a “neutral” rating to an “overweight” rating and lifted their target price for the company from $17.00 to $24.00 in a research report on Friday, January 9th. Weiss Ratings restated a “hold (c-)” rating on shares of Sotera Health in a research note on Monday, December 29th. Barclays upped their price objective on Sotera Health from $19.00 to $20.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. BMO Capital Markets began coverage on Sotera Health in a report on Thursday, November 13th. They issued an “outperform” rating and a $19.00 target price for the company. Finally, Royal Bank Of Canada initiated coverage on Sotera Health in a research note on Thursday, January 8th. They issued an “outperform” rating and a $24.00 price target on the stock.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 6,480,000 shares of Sotera Health stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $16.33, for a total transaction of $105,818,400.00. Following the completion of the sale, the director owned 22,735,301 shares of the company’s stock, valued at approximately $371,267,465.33. The trade was a 22.18% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Pincus & Co. Warburg sold 9,720,000 shares of Sotera Health stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total value of $158,727,600.00. Following the sale, the director directly owned 34,102,952 shares of the company’s stock, valued at approximately $556,901,206.16. This trade represents a 22.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 17,384,104 shares of company stock valued at $284,024,511. Insiders own 47.55% of the company’s stock.

Institutional Trading of Sotera Health

Several hedge funds have recently bought and sold shares of the stock. IFP Advisors Inc lifted its holdings in shares of Sotera Health by 1,105.6% during the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after buying an additional 1,371 shares in the last quarter. Rothschild Investment LLC acquired a new stake in Sotera Health in the 4th quarter worth about $27,000. True Wealth Design LLC boosted its holdings in Sotera Health by 389.3% in the 4th quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock valued at $32,000 after purchasing an additional 1,456 shares during the period. Eurizon Capital SGR S.p.A. bought a new stake in Sotera Health in the 4th quarter valued at about $40,000. Finally, Versant Capital Management Inc grew its position in shares of Sotera Health by 117.6% during the 3rd quarter. Versant Capital Management Inc now owns 2,535 shares of the company’s stock worth $40,000 after purchasing an additional 1,370 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Trading Down 0.5%

Shares of Sotera Health stock opened at $17.37 on Thursday. Sotera Health has a 52-week low of $9.53 and a 52-week high of $19.85. The firm has a market capitalization of $4.93 billion, a PE ratio of 91.43 and a beta of 1.82. The company has a debt-to-equity ratio of 4.04, a current ratio of 2.38 and a quick ratio of 2.18. The company’s fifty day moving average price is $17.91 and its two-hundred day moving average price is $16.45.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.